Purpose

A questionnaire containing some critical questions about practice inside GI endoscopy units in different countries will be distributed via emails. Responses will be collected in an online platform and data will be analyzed to reveal the effect of SARS-CoV-2 pandemic on different aspects of GI endoscopy practice in the studied countries.

Condition

Eligibility

Eligible Ages
Between 30 Years and 70 Years
Eligible Genders
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • physicians working in endoscopy units worldwide

Exclusion Criteria

  • physicians not working in endoscopy units worldwide

Study Design

Phase
Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Arm Groups

ArmDescriptionAssigned Intervention
Practicing gastroenterologists Practicing physicians performing gastrointestinal endoscpy
  • Other: Practice details
    Physicians will report details of their endoscopy practice through answering the questions of the questionnaire

Recruiting Locations

More Details

NCT ID
NCT04342637
Status
Completed
Sponsor
Al-Azhar University

Detailed Description

Participants has to answer the following questions: 1. Participating center data: - Participant name (surname, first name): (optional) - Participant email: (optional) - Country: …….. - Working days (before COVID-19): …….. - Types of procedure performed /day (before COVID-19): ……. - Number of endoscopists /day (before COVID-19): ……. - Number of nursing staff /day (before COVID-19): ……. - Number of administrative staff /day (before COVID-19): ……. - Number of patients undergoing endoscopy/ day (before COVID-19): ……. - Availability of negative pressure rooms (before COVID-19): ……. - Number of endoscopy referrals/ day (before COVID-19): …….. 2. Response to COVID-19: - Working days (after COVID-19): …….. - Types of procedure performed /day (after COVID-19): …….. - Number of endoscopists /day (after COVID-19): …….. - Number of nursing staff /day (after COVID-19): …….. - Number of administrative staff /day (after COVID-19): …….. - Do you consider teams (MD, RN, tech, anesthesia) that remain together for the entire day so as to compartmentalize and minimize personnel exposure? - Number of patients undergoing endoscopy/ day (after COVID-19): …….. - Number of endoscopy referrals/ day (after COVID-19): …….. - Availability of negative pressure rooms or use portable industrial-grade high-efficiency particulate air (HEPA) filters as a reasonable alternative: …….. - Which recommendations do you follow? WEO, AGA, BSG, APSDE, other - Applying triage for patients: e.g. FTOCC (APSDE); dose this include any tests - Do you use any of this for triage of patients: i) a telephone consultation with the referring provider or (ii) a telehealth visit with the patient or (iii) a multidisciplinary team approach or (virtual) disease/tumor board to facilitate decision-making for complicated patients. - Prioritization: Which classification do you use for endoscopic procedures? 1. urgent, semi-urgent and elective during COVID-19 outbreak 2. Time sensitive procedure: - Time-sensitive procedures defined as procedures that if deferred may negatively impact patient-important outcomes. The decision to defer a procedure should be made on a case-by-case basis: - Time-Sensitive* (within 24 hours-8 weeks): 1. Threat to the patient's life or Permanent dysfunction of an organ e.g. diagnosis and treatment of GI bleeding or cholangitis 2. Risk of metastasis or progression of stage of disease e.g. e.g. work up of symptoms suggestive of cancer 3. Risk of rapidly worsening progression of disease or severity of symptoms e.g. management decisions, such as treatment for IBD - Non-Time Sensitive: No short-term impact on patient-important outcomes e.g. screening or surveillance colonoscopy, follow up colonoscopy for +FIT - What are the most common clinical presentations? (please choose all that apply): Upper GI bleeding, lower GI bleeding, cholangitis, suspected cancer, foreign body, relive of GI obstruction, gastrostomy, other 3. Endoscopy and use of PPE: - Did you receive appropriate education and training on infection control measures, including hand hygiene. - Did you receive adequate training on gowning and removal of PPE? - Do you practice Standard hand hygiene procedures before and after each case? - What type of personal protective equipment (PPE) do you usually use for doing an endoscopic procedure nowadays? (choose all that apply) Surgical mask N95 mask Isolation gown with water resistance Head cover Eye protection Face shield N95 protection in combination with face shield or surgical mask Other (please specify): …….. - Do you extend (over 8 hours) use of N95 masks? - Do you re-use of N95 masks? - Do you extend use (over 8 hours) any other equipment? : ….. - Do you re use any other equipment? ….. - If yes, please specify: …… If yes please specify: ….. - Do you use of double gloves? …… - What PPE do you use for the following cases (choose all that apply)? 1. Suspected cases of SARS-CoV-2 infection: Surgical mask N95 mask isolation gown with water resistance head cover eye protection face shield negative pressure room other please specify 2. Probable cases of SARS-CoV-2 infection: Surgical mask N95 mask isolation gown with water resistance head cover eye protection face shield negative pressure room other please specify 3. confirmed cases of SARS-CoV-2 infection: Surgical mask N95 mask isolation gown with water resistance head cover eye protection face shield negative pressure room other please specify 4. Post endoscopy: - Do you motion in your report the status of the patients (suspected, probable, confirmed case of SARS-CoV-2 infection? - Do you use standard endoscopic decontamination or anything extra? - Do you give time for sterilizing endoscopy room after each suspected or confirmed case of SARS-CoV-2 infection? How long? - Do you call back your patients 2 weeks after procedure to ask them about symptoms/ diagnosis of SARS-CoV-2 infection? - Did you report any endoscopy related SARS-CoV-2 infection in your center (anytime for HCWs & up to two weeks after procedures for patients)? - Are you preparing a management plan for the waiting list after the current phase of the pandemic?

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.